Skip to main content
Year archive

Regent Pacific Group Limited — 2021 filings

All 47 regulatory filings released by Regent Pacific Group Limited (575) in 2021, sourced directly from the official regulator.

47 Filings
2021 Period
2021 filings (47)
Filing Released Lang
Licence Agreement with SK-Pharma for the Commercial Launch of Fortacin in Israeli and Balkan Regions and Operations Update
Regulatory Filings
2021-12-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-12-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-11-01 English
Monthly Return of Equity Issuer on Movements in Securities (Revised)
Regulatory Filings
2021-10-15 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-10-04 English
Notification Letter to Non-registered Shareholder and Request Form
Regulatory Filings
2021-09-23 English
Notification Letter to Registered Shareholder and Change Request Form
Regulatory Filings
2021-09-23 English
Interim Report 2021
Regulatory Filings
2021-09-23 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-09-01 English
List of Directors and Their Roles and Functions
Regulatory Filings
2021-08-27 English
Unaudited Interim Results for the Six Months Ended 30 June 2021
Regulatory Filings
2021-08-27 English
Date of Board Meeting
Regulatory Filings
2021-08-17 English
Discloseable Transaction - Disposal of Listed Securities
Regulatory Filings
2021-08-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-08-04 English
Positive Profit Alert
Regulatory Filings
2021-08-03 English
Extremely Encouraging US Market Research Analysis for Fortacin
Regulatory Filings
2021-07-28 English
Supplemental Announcement - Possible Issuance of Shares under General Mandate
Regulatory Filings
2021-07-26 English
Strongly Positive Results of Fortacin US Phase II PRO Validation Study
Regulatory Filings
2021-07-15 English
Launch of MindAge Psychological Aging Clock, Key Appointments to Scientific Advisory Board of Deep Longevity Limited and Possible Issuance of Shares under General Mandate
Regulatory Filings
2021-07-14 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-07-02 English
Change of Company Name, Stock Short Name, Company Logo and Company Website
Regulatory Filings
2021-06-23 English
Supplemental Announcement Relating to Offer to Grant Share Option
Regulatory Filings
2021-06-15 English
Offer to Grant Share Option
Regulatory Filings
2021-06-08 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-06-02 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVES
Regulatory Filings
2021-05-31 English
Poll Results at Annual General Meeting
Regulatory Filings
2021-05-28 English
Operational update
Regulatory Filings
2021-05-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-05-04 English
Notice of Annual General Meeting
Regulatory Filings
2021-04-26 English
Notification Letter and Request Form to Registered Shareholders in relation to the election of means of receipt and language(s) of corporate communications
Regulatory Filings
2021-04-26 English
Form of Proxy for use at the Annual General Meeting to be held on 28 May 2021
Regulatory Filings
2021-04-26 English
(1) Re-election of Directors&#x3b; (2) General mandate to issue new shares&#x3b; (3) General mandate to repurchase the Company's own shares&#x3b; (4) Proposed change of company name&#x3b; and (5)
Regulatory Filings
2021-04-26 English
Annual Report for the year ended 31 December 2020
Regulatory Filings
2021-04-26 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-04-08 English
Operations update: Chinese approval and commercialisation progress - Fortacin
Regulatory Filings
2021-04-01 English
Audited final results for the year ended 31 December 2020 and proposed change of company name
Regulatory Filings
2021-03-31 English
Audited final results for the year ended 31 December 2020 and proposed change of company name
Regulatory Filings
2021-03-30 English
Notice of Board Meeting for audited final results for the year ended 31 December 2020
Regulatory Filings
2021-03-18 English
Profit warning and operational update
Regulatory Filings
2021-03-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-03-02 English
Operations update: Chinese approval and commercialisation progress - Fortacin
Regulatory Filings
2021-02-09 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-02-02 English
Operations update on Fortacin
Regulatory Filings
2021-01-18 English
Discloseable Transaction: Disposal of shares in Tigers Realm Coal Limited
Regulatory Filings
2021-01-13 English
Operations update on Fortacin
Regulatory Filings
2021-01-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2021-01-06 English
Operations update on Fortacin
Regulatory Filings
2021-01-04 English